Corcept Therapeutics Inc
CORT
$72.3+0.82 (+1.15%)
Aug 8, 2025, 4:00 PM
Financials
| 52Week High | 117.33 | 52Week Low | 33.34 |
| Beta | 0.44 | Current Ratio Annual | 3.35 |
| Current Ratio Quarterly | 3.06 | Gross Margin TTM | 98.37 |
| Market Cap | 7.62B | Net Profit Margin TTM | 18.66 |
| Operating Margin TTM | 14.24 | Price To Book | 11.98 |
| Price To Earnings TTM | 57.00 | Price To Free Cash Flow TTM | 42.26 |
| Price To Sales TTM | 10.64 | Quick Ratio Annual | 3.19 |
| Quick Ratio Quarterly | 2.91 | Return On Assets TTM | 16.33 |
| Return On Equity TTM | 20.27 | Return On Investment TTM | 20.27 |
| Revenue Growth3Y | 22.64 | Revenue Growth5Y | 17.11 |
| Revenue Growth Quarterly Yoy | 18.70 | Revenue Growth TTMYoy | 25.71 |
| Revenue Per Share TTM | 5.94 |
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 419 | 103 | 51 | 128 | 140 | 41 | 86.68M | $8.53B |
| Jun 30, 2025 | 182 | 21 | 27 | 73 | 57 | 21 | 21.20M | $1.04B |
| Change | 237(57%) | 82(80%) | 24(47%) | 55(43%) | 83(59%) | 20(49%) | 65.48M(76%) | $7.49B(88%) |